eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | multiple endocrine neoplasia type 1 |
| Comorbidity | C0011854|type 1 diabetes |
| Sentences | 6 |
| PubMedID- 19703761 | Background and aims: once-daily (od) basal insulin glargine (gla) can be used as part of a multiple daily injection regimen in patients with type 1 diabetes mellitus. |
| PubMedID- 25143741 | Idegasp provides similar, noninferior glycemic control to a standard basal-bolus regimen in patients with type 1 diabetes mellitus, with additional benefits of significantly lower episodes of hypoglycemia (particularly nocturnal) and fewer daily insulin injections. |
| PubMedID- 20929418 | Results were similar when restricted to women identified with type 1 diabetes through the diabetes registry. |
| PubMedID- 26435713 | Switching from twice-daily basal insulin injections to once-daily insulin degludec injection for basal-bolus insulin regimen in japanese patients with type 1 diabetes: a pilot study. |
| PubMedID- 24115523 | We conducted a cross-sectional study in 240 men including 80 men with type 1 diabetes (t1d), 80 men with t2d and 80 men without diabetes. |
| PubMedID- 21437110 | However, it has been shown to be noninferior to lispro in terms of efficacy and safety as part of a basal-bolus regimen in pediatric patients with type 1 diabetes.25 it is thus a safe and effective short-acting insulin option in this population. |
Page: 1